• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1
1
1
1
1

COUNTRY

1
1

CATEGORIES

  • 4
  • 1

PRICE

1
1
3
5

PUBLISHED

0
2
3
5

PRODUCT TYPE

5

Search "Shanghai Fosun Pharmaceutical Group Co., Ltd.-Therapeutic Competitors Report" returned 5 results.

PRODUCT TITLE

Domestic Chinese Biopharmaceutical Companies

Whether your organization (or department) views domestic Chinese pharmaceutical companies as a competitor, complementor, or as a catalyst, they are becoming an increasing force in the global healthcare...

April 2011
FROM
Competitor Analysis: Insulin Competitor Analysis: Insulin - Product Thumbnail Image

Competitor Analysis: Insulin

The Competitive Intelligence Report Insulin as of January 2011 provides a competitor analysis in the development pipeline of novel insulin-based products for treatment of type 1 and 2 diabetes Purchase...

January 2011
FROM

Type 2 Diabetes - Pipeline Review, H2 2014

Type 2 Diabetes - Pipeline Review, H2 2014 Summary This, ‘Type 2 Diabetes - Pipeline Review, H2 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Type 2 Diabetes - Pipeline Review, H1 2015

Type 2 Diabetes - Pipeline Review, H1 2015 Summary This, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM
Global Biosimilars Industry 2015 Global Biosimilars Industry 2015 - Product Thumbnail Image Special Offer Sale Banner

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

February 2015
FROM
Loading Indicator

Our Clients

Goodyear Tire & Rubber Company GlaxoSmithKline PLC Hilton Worldwide Hewlett-Packard Company Accenture PLC. Qualcomm Incorporated UBS AG